European Journal of Molecular & Clinical Medicine

Abstract

Aim: The aim of our study is to assess the role of multiparametric MR imaging in differentiation of brain tumors.
Methods: This was a cross sectional, descriptive study which was conducted between August 2020 to September 2022 at Dr. D. Y. Patil Medical College and Hospital and Research Centre, Pimpri, Pune. Institutional scientific and Ethics committee clearance for conducting the study was obtained prior to starting the study.50 patients, who were meeting the inclusion criteria of the study, were included in the study. A written and informed consent was taken from all the patients.
Results: It was seen that in the present study, 56 % of the patients were males whereas 44 % were females. It was observed that headache was the presenting complaint in about 60 % of the patients and it was the common presenting symptom. Vomiting and seizures were the other common presenting symptoms accounting for 26% each. Giddiness was noted in 18% of the patients, whereas hemiparesis was seen in 14 % of the patients. It was observed that meningioma was the most common diagnosis accounting for about 20 % of the total cases, followed by astrocytoma which accounted for 18 % of the total cases. The other diagnosis observed were low grade glioma, glioblastoma multiforme observed in 12 % patients each.
Conclusion: Various newer advanced functional MR imaging sequences such as perfusion imaging and tensor imaging provide crucial additional information in the imaging of brain tumors. Conventional sequences help in diagnosing tumors and giving necessary information regarding appearance, however they have certain limitations for which newer advanced MR imaging techniques such as  Diffusion weighted imaging (DWI) along with ADC ratios has opened up the possibilities to study tumoral and peritumoral tissue characteristics based on water diffusion findings, and providing clinicians a whole new approach towards better management of brain tumors and  differentiation of low grade tumors from high grade tumors.